BioNanomatrix Inc Announces Appointment of Dr. Paul R. Selvin to Its Scientific Advisory Board
BioNanomatrix Inc wins Ben Franklin Emerging Business Awards, April 2008
The $100 Genome, MIT Technology Review, April 2008
Battelle Ventures leads Series A round investment in BioNanomatrix Inc, Mar 2008
Wanted: $ 100 Genome, NATURE Biotechnology, Nov 2007
Decoding DNA quickly and cheaply, PHILADELPHIA INQUIRER, Nov 2007
BioNanomatrix Inc. and Agilent Technologies Inc. (NYSE: A) to develop new generation genetic analysis system using nanoscale whole genome imaging technology, Nov 2007
BioNanomatrix and Complete Genomics receive $8.8 Million NIST-ATP award to develop sequencing platform for $ 100 genome, Sept 2007
BioNanomatrix and Princeton University receive two year grant from National Cancer Institute of NIH to develop advanced nanofluidic system in cancer diagnostics and research, Sept 2007
BioNanomatrix announces issuance of key nanofluidics patent enabling single molecule whole genome analysis, Sept 2007
BioNanomatrix signs a Cooperative Research and Development Agreement for cancer diagnostics with the National Cancer Institute, Jan 2007
BioNanomatrix awarded two year grant from National Human Genome Research Institute of NIH to develop new nanoscale whole genome analyzer, Sept 2006
BioNanomatrix receives two year grant from National Cancer Institute and financing from 21 Ventures and Ben Franklin Technology Partners SEP, May 2006
